# Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

> **NCT01404364** · NA · COMPLETED · sponsor: **Hospital Governador Celso Ramos** · enrollment: 36 (actual)

## Conditions studied

- Blind Painful Eye
- Refractory Glaucoma
- Control of Pain Through Drug Injection

## Interventions

- **DRUG:** Triamcinolone
- **DRUG:** Chlorpromazine

## Key facts

- **NCT ID:** NCT01404364
- **Lead sponsor:** Hospital Governador Celso Ramos
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404364, "Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01404364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*